CERA

Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

World Glaucoma Week 2025

Donate this World Glaucoma Week (9-15 March) and support our work to find new ways to diagnose and treat glaucoma.

Video

Watch pioneering ocular gene therapy researcher Professor Jean Bennett deliver an engaging and enlightening presentation on pioneering treatments for blinding retinal disorders for the 15th annual Gerard Crock Lecture.  

Video

In this video, learn about how CERA’s research into gene therapies could transform the treatment of eye disease.

Consumer involvement

Our new Consumer Program is working alongside people with lived experience to ensure their insights are at the heart of advancing eye research. Learn about the program and meet our Consumer Advisory Group.

Celebrating Cerulea Clinical Trials

Cerulea Clinical Trials, CERA’s new not-for-profit clinical trials centre, is up and running.
Learn how Cerulea will transform the delivery of ophthalmic clinical trials, increase community access to sight-saving therapies and deliver excellence for clinicians, trial participants and sponsors.

Read more

Take part in research

Help shape the future of vision research by taking part in a clinical study.
Find out how you can take part in studies at CERA and Cerulea Clinical Trials for eye conditions including age-related macular degeneration, corneal conditions, diabetic retinopathy, glaucoma and inherited retinal disease.

Learn more

Latest News


Stories

22 March 2025

Artist and great grandmother Lesley Hunter hopes to help others see by taking part in glaucoma research.

Research

03 March 2025

Associate Professor Zhichao Wu’s project to improve glaucoma diagnosis and treatment has been recognised as one of the nation’s best.

Research

03 March 2025

Pioneering CERA research is shedding light on new cell types that may hold clues for the future of glaucoma treatments.

News

03 March 2025

CERA’s new Head of Philanthropy is passionate about helping people transform the lives of others.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals